Giambattista Gazzola

Suggest Changes
Learn More
BACKGROUND Sublingual immunotherapy (SLIT) is currently considered a valid option to subcutaneous immunotherapy (SCIT), but only a few studies made a direct comparison of their effectiveness. The aim(More)
  • 1